Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

Episode 176: Journal Club with Drs. Ferhina and M. Ali Khan discussing Preoperative Anti-VEGF, RD after Intravitreal Injection, and Influence of CATT Trial Results
Jayanth Sridhar, MD
Member Podcasts
2019
Potential Safety Concerns of Bevacizumab
Robert L. Avery, MD
Updates from the Field
2017
Intravitreal Injections: Logistics, Safety, and Pearls
Andrew A. Moshfeghi, MD, MBA
Webinars and Journal Clubs
2018

Category: Pharmacology

See more